How does pulmonary hypertension cause tricuspid and mitral valve regurgitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanisms of Pulmonary Hypertension-Induced Valvular Regurgitation

Tricuspid Regurgitation

Pulmonary hypertension causes tricuspid regurgitation primarily through right ventricular systolic pressure elevation leading to RV cavity enlargement, tricuspid annular dilatation, and papillary muscle displacement with leaflet tethering—all occurring with structurally normal valve leaflets. 1

Primary Pathophysiologic Mechanisms

  • RV pressure overload from elevated pulmonary artery pressures directly increases RV systolic pressure, which initiates a cascade of structural changes even when the tricuspid valve itself is anatomically normal 1

  • Progressive RV remodeling occurs as the ventricle dilates in response to chronic pressure overload, with the cavity enlargement causing geometric distortion of the subvalvular apparatus 1, 2

  • Tricuspid annular dilatation develops as the RV enlarges, with the annulus losing its normal saddle shape and becoming flat, planar, and distorted—this is considered the most important factor in functional TR development 1

  • Papillary muscle displacement occurs with RV dilatation, causing leaflet tethering that prevents adequate coaptation during systole 1, 3

Hemodynamic Thresholds

  • Systolic pulmonary artery pressures exceeding 55 mm Hg are likely to cause TR with anatomically normal tricuspid valves, whereas TR occurring with systolic pulmonary artery pressures below 40 mm Hg typically reflects structural valve abnormalities 1

  • The severity of TR correlates directly with the degree of pulmonary hypertension, with severe TR associated with higher right atrial pressures (mean 15 mm Hg vs 10 mm Hg) and lower cardiac index (2.2 L/min/m² vs 2.8 L/min/m²) 4

Self-Perpetuating Cycle

  • TR itself worsens RV function by creating volume overload superimposed on the existing pressure overload, leading to further RV dilatation, more annular dilatation and tethering, and progressively worsening TR 1

  • Right atrial enlargement accompanies this process, with 91% of patients with severe TR demonstrating right atrial dilatation compared to 47% in those with mild or no TR 4

  • Ventricular interdependence develops in advanced cases, where the dilated RV shifts the interventricular septum toward the left ventricle, potentially reducing LV cavity size and causing restricted LV filling with increased LV diastolic and pulmonary artery pressures 1

Clinical Implications

  • Severe TR is strongly predictive of mortality in pulmonary hypertension, with an adjusted hazard ratio of 1.83 for 5-year mortality risk even after controlling for age, functional class, and pulmonary vascular resistance 4

  • The presence of a pansystolic murmur of tricuspid regurgitation reflects elevated right ventricular pressures and is a key physical examination finding in pulmonary arterial hypertension 5

Mitral Regurgitation

Pulmonary hypertension causes mitral regurgitation through an indirect mechanism involving left ventricular dysfunction from ventricular interdependence, though this is far less common than tricuspid regurgitation and typically occurs only in advanced disease with severe RV failure.

Mechanism of Ventricular Interdependence

  • Septal shift occurs when the dilated, failing RV causes the interventricular septum to bow toward the left ventricle during diastole, reducing LV cavity size and altering LV geometry 1

  • This geometric distortion can affect mitral valve apparatus geometry, potentially causing functional mitral regurgitation through altered papillary muscle position and leaflet coaptation 1

Important Clinical Distinction

  • Mitral regurgitation in the context of pulmonary hypertension is more commonly the primary pathology causing secondary pulmonary hypertension, rather than pulmonary hypertension causing mitral regurgitation 6

  • In patients with rheumatic mitral valve disease and secondary pulmonary hypertension, functional tricuspid regurgitation is far more common than any worsening of the primary mitral pathology 6

Prognosis After Mitral Intervention

  • When mitral regurgitation is the primary lesion causing pulmonary hypertension, the concomitant tricuspid regurgitation may improve after mitral valve repair if pulmonary hypertension is severe and the tricuspid valve anatomy is not grossly distorted 7

  • However, improvement is less likely when significant tricuspid annular dilatation has already occurred, and functional tricuspid regurgitation persists or progresses in patients with advanced right ventricular dysfunction despite successful mitral valve replacement 7, 6

  • Functional tricuspid regurgitation regressed in 38 of 42 survivors with severe pulmonary hypertension after mitral valve replacement, but persisted or progressed in 22 of 34 survivors with impaired right ventricular function 6

Key Pitfall to Avoid

  • Do not assume mitral regurgitation will automatically improve pulmonary hypertension-related tricuspid regurgitation—patients with moderate or greater TR at the time of mitral surgery should be considered for concomitant tricuspid intervention, especially if tricuspid annular dilatation is present 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2017

Research

Impact of pulmonary hypertension on tricuspid valve function.

Annals of biomedical engineering, 2013

Guideline

Physical Examination Findings in Pulmonary Arterial Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Development of Pulmonary Hypertension and Worsened Tricuspid Regurgitation After Mitral Valve Repair

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended treatment and management plan for a patient with mild mitral and tricuspid regurgitation, mild pulmonary hypertension, and a stable liver cyst?
What is the management approach for a patient with normal left and right ventricular size and function, mild mitral and tricuspid regurgitation, and mild pulmonary hypertension?
What is the treatment plan for a dialysis patient with chronic cough, left ventricular hypertrophy (LVH), normal ejection fraction (EF), severe tricuspid regurgitation (TR), and pulmonary hypertension?
What is the next treatment option for a 66-year-old male with abnormal paradoxical septal motion, right ventricular volume overload, elevated right ventricular end-diastolic pressure, left atrial enlargement, mild mitral valve stenosis, moderate pulmonary hypertension, mild tricuspid valve regurgitation, and a dilated inferior vena cava?
Why do patients develop pulmonary hypertension and worsened tricuspid regurgitation after mitral valve repair, and can this improve over time with surgical recovery?
What are the signs of factitious dermatitis pathology?
What is the management approach for a non-alcoholic patient presenting with hematemesis (vomiting blood) and splenomegaly (enlarged spleen) with a normal liver size and echo texture?
What is the optimal dose of aripiprazole for treating depression, 5mg or 2.5mg?
What are the uses and benefits of tyrosine supplementation?
What is the treatment for eye exposure to Lysol (disinfectant)?
What causes a stye?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.